Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(3,5-dimethyl-1H-pyrazol-1-yl) (m-tolyl)methanone
-
(3,5-dimethyl-1H-pyrazol-1-yl) (naphthalen-2-yl)methanone
-
(3,5-dimethyl-1H-pyrazol-1-yl) (o-tolyl)methanone
-
(3,5-dimethyl-1H-pyrazol-1-yl) (pyridin-4-yl)methanone
-
(4-aminophenyl) (3,5-dimethyl-1H-pyrazol-1-yl)methanone
-
(4-aminophenyl) (3,5-dimethyl-4-(p-tolyloxy)-1H-pyrazol-1-yl)methanone
-
(4-aminophenyl) (4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methanone
-
(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl) (4-chlorophenyl)methanone
-
(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl) (m-tolyl)methanone
-
(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl) (naphthalen-2-yl)methanone
-
(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl) (o-tolyl)methanone
-
(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl) (p-tolyl)methanone
-
(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl) (pyridin-4-yl)methanone
-
(4-chlorophenyl) (3,5-dimethyl-1H-pyrazol-1-yl)methanone
-
(4-chlorophenyl) (3,5-dimethyl-4-(p-tolyloxy)-1H-pyrazol-1-yl)methanone
-
(E)-1-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)-3-phenylprop-2-en-1-one
-
(R)-1-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)-2-(4-isobutylphenyl)propan-1-one
-
1-(4-aminobenzoyl)-5-methyl-1H-pyrazol-3(2H)-one
-
3,5-dimethyl-4-(naphthalen-2-yloxy)-1H-pyrazole
-
3-methyl-2-(4-methylbenzoyl)-1,2-dihydropyrazol-5-one
-
ammonium heptamolybdate
AHM, (NH4)6[Mo7O24]
polytungstate salt POM-1
Na6[H2W12O40]
-
(3,5-dimethyl-1H-pyrazol-1-yl) (m-tolyl)methanone
-
(3,5-dimethyl-1H-pyrazol-1-yl) (naphthalen-2-yl)methanone
-
(3,5-dimethyl-1H-pyrazol-1-yl) (o-tolyl)methanone
-
(3,5-dimethyl-1H-pyrazol-1-yl) (pyridin-4-yl)methanone
-
(4-aminophenyl) (3,5-dimethyl-1H-pyrazol-1-yl)methanone
-
(4-aminophenyl) (3,5-dimethyl-4-(p-tolyloxy)-1H-pyrazol-1-yl)methanone
-
(4-aminophenyl) (4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methanone
-
(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl) (4-chlorophenyl)methanone
-
(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl) (m-tolyl)methanone
-
(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl) (naphthalen-2-yl)methanone
-
(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl) (o-tolyl)methanone
-
(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl) (p-tolyl)methanone
-
(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl) (pyridin-4-yl)methanone
-
(4-chlorophenyl) (3,5-dimethyl-1H-pyrazol-1-yl)methanone
-
(4-chlorophenyl) (3,5-dimethyl-4-(p-tolyloxy)-1H-pyrazol-1-yl)methanone
-
(E)-1-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)-3-phenylprop-2-en-1-one
-
(R)-1-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)-2-(4-isobutylphenyl)propan-1-one
-
1-(4-aminobenzoyl)-5-methyl-1H-pyrazol-3(2H)-one
-
1-amino-4-[(naphthalen-1-yl)amino]-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid
-
3,5-dimethyl-4-(naphthalen-2-yloxy)-1H-pyrazole
-
3-methyl-2-(4-methylbenzoyl)-1,2-dihydropyrazol-5-one
-
ADP
-
hydrolysis of CaATP2- and CaADP- decreased by 50% at 0.48 mM free ADP
ATP
-
hydrolysis of CaATP2- and CaADP- decreased by 50% at 0.3 mM free ATP
Evans blue
-
complete inhibition at 0.1 mM
orthovanadate
-
0.1 mM, 45% inhibition of ATPase activity
NaN3
-
-
Sodium azide
-
-
Sodium azide
-
not inhibitory at 1 mM, 25% inhibition of ATPase activity at 20 mM
suramin
-
-
suramin
-
0.25 mM, 19% inhibition of ATPase activity
additional information
inhibition mechanism of polyoxometallates, overview
-
additional information
synthesis of aryl pyrazole derivatives using 1,3-dicarbonyl motifs. Synthesis of (3,5-dimethyl-1H-pyrazol-1-yl) (phenyl)methanones and (4-chloro-3,5-dimethyl-1H-pyrazol-1-yl) (phenyl)methanones by grinding equimolar concentrations of pentane-2,4-dione and 3-chloropentane-2,4-dione with different arylhydrazides, respectively. The compounds can be regarded as 1H-pyrazol-1-yl-one analogues and represent drug like molecules. Structure-activity relationships, FT-IR, 1H NMR, 13C NMR and mass spectroscopic structure analysis, overview. Effects of these synthesized compounds on different isozymes of nucleoside triphosphate diphosphohydrolases, NTPDases
-
additional information
synthesis of aryl pyrazole derivatives using 1,3-dicarbonyl motifs. Synthesis of (3,5-dimethyl-1H-pyrazol-1-yl) (phenyl)methanones and (4-chloro-3,5-dimethyl-1H-pyrazol-1-yl) (phenyl)methanones by grinding equimolar concentrations of pentane-2,4-dione and 3-chloropentane-2,4-dione with different arylhydrazides, respectively. The compounds can be regarded as 1H-pyrazol-1-yl-one analogues and represent drug like molecules. Structure-activity relationships, FT-IR, 1H NMR, 13C NMR and mass spectroscopic structure analysis, overview. Effects of these synthesized compounds on different isozymes of nucleoside triphosphate diphosphohydrolases, NTPDases
-
additional information
synthesis of aryl pyrazole derivatives using 1,3-dicarbonyl motifs. Synthesis of (3,5-dimethyl-1H-pyrazol-1-yl) (phenyl)methanones and (4-chloro-3,5-dimethyl-1H-pyrazol-1-yl) (phenyl)methanones by grinding equimolar concentrations of pentane-2,4-dione and 3-chloropentane-2,4-dione with different arylhydrazides, respectively. The compounds can be regarded as 1H-pyrazol-1-yl-one analogues and represent drug like molecules. Structure-activity relationships, FT-IR, 1H NMR, 13C NMR and mass spectroscopic structure analysis, overview. Effects of these synthesized compounds on different isozymes of nucleoside triphosphate diphosphohydrolases, NTPDases
-
additional information
synthesis of aryl pyrazole derivatives using 1,3-dicarbonyl motifs. Synthesis of (3,5-dimethyl-1H-pyrazol-1-yl) (phenyl)methanones and (4-chloro-3,5-dimethyl-1H-pyrazol-1-yl) (phenyl)methanones by grinding equimolar concentrations of pentane-2,4-dione and 3-chloropentane-2,4-dione with different arylhydrazides, respectively. The compounds can be regarded as 1H-pyrazol-1-yl-one analogues and represent drug like molecules. Structure-activity relationships, FT-IR, 1H NMR, 13C NMR and mass spectroscopic structure analysis, overview. Effects of these synthesized compounds on different isozymes of nucleoside triphosphate diphosphohydrolases, NTPDases
-
additional information
-
no inhibition by orthovanadate
-
additional information
-
no inhibition by orthovanadate
-
additional information
-
no inhibition by orthovanadate
-
additional information
-
no inhibition by N-ethylmaleimide
-
additional information
-
no inhibition by levamisole
-
additional information
-
no inhibition by ouabain
-
additional information
-
no inhibition by ouabain
-
additional information
-
no inhibition by ouabain
-
additional information
-
no inhibition by NEM
-
additional information
-
no inhibition by oligomycin
-
additional information
-
no inhibition by oligomycin
-
additional information
-
no inhibition by oligomycin
-
additional information
-
no inhibition by oligomycin
-
additional information
-
no inhibition by lanthanum
-
additional information
-
no inhibition by lanthanum
-
additional information
-
no inhibition by P1,P5-di(adenosine-5'-)pentanphospate
-
additional information
-
not inhibitory: oligomycin, ouabain, bafilomycin A, theophylline, thapsigarin, ethacrynic acid, P1,P5-(adenosine-5)pentyphosphate, omeprazole
-
additional information
-
not inhibitory: ouabain, N-ethylmaleimide, lanthanum, oligomycin, levamisole, cAMP
-
additional information
synthesis of aryl pyrazole derivatives using 1,3-dicarbonyl motifs. Synthesis of (3,5-dimethyl-1H-pyrazol-1-yl) (phenyl)methanones and (4-chloro-3,5-dimethyl-1H-pyrazol-1-yl) (phenyl)methanones by grinding equimolar concentrations of pentane-2,4-dione and 3-chloropentane-2,4-dione with different arylhydrazides, respectively. The compounds can be regarded as 1H-pyrazol-1-yl-one analogues and represent drug like molecules. Structure-activity relationships, FT-IR, 1H NMR, 13C NMR and mass spectroscopic structure analysis, overview. Effects of these synthesized compounds on different isozymes of nucleoside triphosphate diphosphohydrolases, NTPDases
-
additional information
synthesis of aryl pyrazole derivatives using 1,3-dicarbonyl motifs. Synthesis of (3,5-dimethyl-1H-pyrazol-1-yl) (phenyl)methanones and (4-chloro-3,5-dimethyl-1H-pyrazol-1-yl) (phenyl)methanones by grinding equimolar concentrations of pentane-2,4-dione and 3-chloropentane-2,4-dione with different arylhydrazides, respectively. The compounds can be regarded as 1H-pyrazol-1-yl-one analogues and represent drug like molecules. Structure-activity relationships, FT-IR, 1H NMR, 13C NMR and mass spectroscopic structure analysis, overview. Effects of these synthesized compounds on different isozymes of nucleoside triphosphate diphosphohydrolases, NTPDases
-
additional information
synthesis of aryl pyrazole derivatives using 1,3-dicarbonyl motifs. Synthesis of (3,5-dimethyl-1H-pyrazol-1-yl) (phenyl)methanones and (4-chloro-3,5-dimethyl-1H-pyrazol-1-yl) (phenyl)methanones by grinding equimolar concentrations of pentane-2,4-dione and 3-chloropentane-2,4-dione with different arylhydrazides, respectively. The compounds can be regarded as 1H-pyrazol-1-yl-one analogues and represent drug like molecules. Structure-activity relationships, FT-IR, 1H NMR, 13C NMR and mass spectroscopic structure analysis, overview. Effects of these synthesized compounds on different isozymes of nucleoside triphosphate diphosphohydrolases, NTPDases
-
additional information
synthesis of aryl pyrazole derivatives using 1,3-dicarbonyl motifs. Synthesis of (3,5-dimethyl-1H-pyrazol-1-yl) (phenyl)methanones and (4-chloro-3,5-dimethyl-1H-pyrazol-1-yl) (phenyl)methanones by grinding equimolar concentrations of pentane-2,4-dione and 3-chloropentane-2,4-dione with different arylhydrazides, respectively. The compounds can be regarded as 1H-pyrazol-1-yl-one analogues and represent drug like molecules. Structure-activity relationships, FT-IR, 1H NMR, 13C NMR and mass spectroscopic structure analysis, overview. Effects of these synthesized compounds on different isozymes of nucleoside triphosphate diphosphohydrolases, NTPDases
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.1712
AMPCPP
recombinant wild-type enzyme, pH 7.4, 25°C
0.009
GTP
recombinant wild-type enzyme, pH 7.4, 25°C
0.0105
IDP
recombinant wild-type enzyme, pH 7.4, 25°C
0.0108
ITP
recombinant wild-type enzyme, pH 7.4, 25°C
0.7495
TDP
recombinant wild-type enzyme, pH 7.4, 25°C
0.777
CDP
-
pH 7.5, 37°C, presence of Mg2+
0.148
CTP
-
pH 7.5, 37°C, presence of Mg2+
0.357
GDP
-
pH 7.5, 37°C, presence of Mg2+
0.164
GTP
-
pH 7.5, 37°C, presence of Mg2+
0.622
IDP
-
pH 7.5, 37°C, presence of Mg2+
0.259
ITP
-
pH 7.5, 37°C, presence of Mg2+
0.555
UDP
-
pH 7.5, 37°C, presence of Mg2+
0.207
UTP
-
pH 7.5, 37°C, presence of Mg2+
additional information
additional information
kinetics, overview
-
0.0025
ADP
recombinant mutant EDC K257M, pH 7.4, 25°C
0.0025
ADP
recombinant mutant EDC Y314F, pH 7.4, 25°C
0.0047
ADP
recombinant wild-type enzyme, pH 7.4, 25°C
0.0051
ADP
recombinant mutant EDC Y409F, pH 7.4, 25°C
0.0059
ADP
recombinant mutant EDC DELTA MIL, pH 7.4, 25°C
0.0114
GDP
recombinant wild-type enzyme, pH 7.4, 25°C
0.0131
GDP
in presence of 0.1 mM UMP, recombinant wild-type enzyme, pH 7.4, 25°C
0.0488
GDP
in presence of 0.1 mM AMP, recombinant wild-type enzyme, pH 7.4, 25°C
0.149
GDP
in presence of 0.1 mM AHM, recombinant wild-type enzyme, pH 7.4, 25°C
0.0113
UDP
recombinant wild-type enzyme, pH 7.4, 25°C
0.0175
UDP
recombinant mutant EDC DELTA MIL, pH 7.4, 25°C
0.01
UTP
recombinant wild-type enzyme, pH 7.4, 25°C
0.0129
UTP
recombinant mutant EDC DELTA MIL, pH 7.4, 25°C
0.031
ADP
-
CaADP-
0.15
ADP
-
pH 7.5, 37°C, presence of Mg2+
0.167
ADP
-
pH 7.4, 37°C, presence of Ca2+
0.196
ADP
-
pH 7.5, 37°C, presence of Ca2+
0.024
ATP
-
CaATP2-
0.083
ATP
-
pH 7.5, 37°C, presence of Mg2+
0.085
ATP
-
pH 7.5, 37°C, presence of Ca2+
0.141
ATP
-
pH 7.4, 37°C, presence of Ca2+
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Beaudoin, A.R.; Vachereau, A.; Grondin, G.; St-Jean, P.; Rosenberg, M.D.; Strobel, R.
Microvesicular secretion, a mode of cell secretion associated with the presence of an ATP-diphosphohydrolase
FEBS Lett.
203
1-2
1986
Rattus norvegicus
brenda
Heine, P.; Braun, N.; Heilbronn, A.; Zimmermann, H.
Functional characterization of rat ecto-ATPase and ecto-ATP diphosphohydrolase after heterologous expression in CHO cells
Eur. J. Biochem.
262
102-107
1999
Rattus norvegicus
brenda
De Oliveira, M.E.; Battastini, O.A.M.; Meirelles, M.N.; Moreira, M.C.; Dias, R.D.; Sarkis, J.J.
Characterization and localisation of an ATP diphosphohydrolase activity (EC 3.6.1.5) in sarcolemmal membrane from rat heart
Mol. Cell. Biochem.
170
115-123
1997
Rattus norvegicus
brenda
Valenzuela, M.A; Ketttlun, A.M.; Sandoval, S.; Garcia, L.; Mancilla, M.; Neckelmann, G.; Chayet, L.; Alvarez, A.; Cuevas, F.; Collados, L.; Espinosa, V.; Traverso-Cori, A.; Bravo, I.; Acevedo, C.G.; Aranda, E.
Comparison of the biochemical properties, regulation and function of ATP diphosphohydrolase from human placenta and rat kidney
Braz. J. Med. Biol. Res.
29
589-597
1996
Homo sapiens, Rattus norvegicus
brenda
Battastini, A.M.O.; Oliveira, E.M.; Moreira, C.M.; Bonan, C.D; Sarkis, J.J; Dias, R.D.
Solubilization and characterization of an ATP diphosphohydrolase (EC 3.6.1.5) from rat brain synaptic plasma membranes
Biochem. Mol. Biol. Int.
37
209-219
1995
Rattus norvegicus
brenda
Frassetto, S.S.; Dias, R.D.; Sarkis, J.J.
Inhibition and kinetic alterations by excess free ATP and ADP of the ATP disphosphohydrolase activity (EC 3.6.1.5) from rat blood platelets
Biochem. Mol. Biol. Int.
35
499-506
1995
Rattus norvegicus
brenda
Frassetto, S.S.; Dias, R.D.; Sarkis, J.J.
Characterization of an ATP diphosphohydrolase activity (apyrase EC 3.6.1.5) in rat blood platelets
Mol. Cell. Biochem.
129
47-55
1993
Rattus norvegicus
brenda
Demenis, M.A.; Furriel, R.P.M.; Leone, F.A.
Characterization of an ectonucleoside triphosphate diphosphohydrolase 1 activity in alkaline phosphatase-depleted rat osseous plate membranes: possible functional involvement in the calcification process
Biochim. Biophys. Acta
1646
216-225
2003
Rattus norvegicus
brenda
Heine, P.; Braun, N.; Sevigny, J.; Robson, S.C.; Servos, J.; Zimmermann, H.
The C-terminal cysteine-rich region dictates specific catalytic properties in chimeras of the ectonucleotidases NTPDase1 and NTPDase2
Eur. J. Biochem.
268
364-373
2001
Rattus norvegicus
brenda
Failer, B.U.; Aschrafi, A.; Schmalzing, G.; Zimmermann, H.
Determination of native oligomeric state and substrate specificity of rat NTPDase1 and NTPDase2 after heterologous expression in Xenopus oocytes
Eur. J. Biochem.
270
1802-1809
2003
Rattus norvegicus
brenda
Bruno, A.N.; Bonan, C.D.; Wofchuk, S.T.; Sarkis, J.J.; Battastini, A.M.
ATP diphosphohydrolase (NTPDase 1) in rat hippocampal slices and effect of glutamate on the enzyme activity in different phases of development
Life Sci.
71
215-225
2002
Rattus norvegicus
brenda
Pierre Oses, J.; Cardoso, C.M.; Albuquerque Germano, R.; Barreto Kirst, I.; Rucker, B.; Ribas Furstenau, C.; Wink, M.R.; Bonan, C.D.; Oliveira Battastini, A.M.; Freitas Sarkis, J.J.
Soluble NTPDase: An additional system of nucleotide hydrolysis in rat blood serum
Life Sci.
74
3275-3284
2004
Rattus norvegicus
brenda
Boeck, C.R.; Sarkis, J.J.; Vendite, D.
Kinetic characterization and immunodetection of ecto-ATP diphosphohydrolase (EC 3.6.1.5) in cultured hippocampal neurons
Neurochem. Int.
40
449-453
2002
Rattus norvegicus
brenda
Nedeljkovic, N.; Banjac, A.; Horvat, A.; Stojiljkovic, M.; Nikezic, G.
Ecto-ATPase and ecto-ATP-diphosphohydrolase are co-localized in rat hippocampal and caudate nucleus synaptic plasma membranes
Physiol. Res.
52
797-804
2003
Rattus norvegicus
brenda
Henz, S.L.; Ribeiro, C.G.; Rosa, A.; Chiarelli, R.A.; Casali, E.A.; Sarkis, J.J.
Kinetic characterization of ATP diphosphohydrolase and 5'-nucleotidase activities in cells cultured from submandibular salivary glands of rats
Cell Biol. Int.
30
214-220
2006
Rattus norvegicus
brenda
Vlajkovic, S.M.; Vinayagamoorthy, A.; Thorne, P.R.; Robson, S.C.; Wang, C.J.; Housley, G.D.
Noise-induced up-regulation of NTPDase3 expression in the rat cochlea: Implications for auditory transmission and cochlear protection
Brain Res.
1104
55-63
2006
Rattus norvegicus
brenda
Nedeljkovic, N.; Banjac, A.; Horvat, A.; Stojiljkovic, M.; Nikezic, G.
Developmental profile of NTPDase activity in synaptic plasma membranes isolated from rat cerebral cortex
Int. J. Dev. Neurosci.
23
45-51
2005
Rattus norvegicus
brenda
Barreto-Chaves, M.L.; Carneiro-Ramos, M.S.; Cotomacci, G.; Junior, M.B.; Sarkis, J.J.
E-NTPDase 3 (ATP diphosphohydrolase) from cardiomyocytes, activity and expression are modulated by thyroid hormone
Mol. Cell. Endocrinol.
251
49-55
2006
Rattus norvegicus
brenda
Belcher, S.M.; Zsarnovszky, A.; Crawford, P.A.; Hemani, H.; Spurling, L.; Kirley, T.L.
Immunolocalization of ecto-nucleoside triphosphate diphosphohydrolase 3 in rat brain: Implications for modulation of multiple homeostatic systems including feeding and sleep-wake behaviors
Neuroscience
137
1331-1346
2006
Rattus norvegicus
brenda
Fausther, M.; Lecka, J.; Soliman, E.; Kauffenstein, G.; Pelletier, J.; Sheung, N.; Dranoff, J.; Sevigny, J.
Coexpression of ecto-5'-nucleotidase/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver
Am. J. Physiol. Gastrointest. Liver Physiol.
302
447-459
2012
Rattus norvegicus (O35795), Rattus norvegicus (P97687), Rattus norvegicus (Q5DRK1), Rattus norvegicus Sprague-Dawley (O35795), Rattus norvegicus Sprague-Dawley (P97687), Rattus norvegicus Sprague-Dawley (Q5DRK1)
brenda
Zebisch, M.; Krauss, M.; Schaefer, P.; Straeter, N.
Crystallographic evidence for a domain motion in rat nucleoside triphosphate diphosphohydrolase (NTPDase) 1
J. Mol. Biol.
415
288-306
2012
Rattus norvegicus (P97687)
brenda
Zebisch, M.; Baqi, Y.; Schaefer, P.; Mueller, C.E.; Straeter, N.
Crystal structure of NTPDase2 in complex with the sulfoanthraquinone inhibitor PSB-071
J. Struct. Biol.
185
336-341
2014
Rattus norvegicus (O35795)
brenda
Beckenkamp, L.R.; Iser, I.C.; Onzi, G.R.; Fontoura, D.M.S.D.; Bertoni, A.P.S.; Sevigny, J.; Lenz, G.; Wink, M.R.
Characterization of soluble CD39 (SolCD39/NTPDase1) from PiggyBac nonviral system as a tool to control the nucleotides level
Biochem. J.
476
1637-1651
2019
Rattus norvegicus (P97687)
brenda
Channar, P.A.; Afzal, S.; Ejaz, S.A.; Saeed, A.; Larik, F.A.; Mahesar, P.A.; Lecka, J.; Sevigny, J.; Erben, M.F.; Iqbal, J.
Exploration of carboxy pyrazole derivatives synthesis, alkaline phosphatase, nucleotide pyrophosphatase/phosphodiesterase and nucleoside triphosphate diphosphohydrolase inhibition studies with potential anticancer profile
Eur. J. Med. Chem.
156
461-478
2018
Rattus norvegicus (O35795), Rattus norvegicus (P97687), Rattus norvegicus (Q5DRK1), Rattus norvegicus (Q80Z26)
brenda